Spinal Cord InjuriesTetra-MouvNCT05094752
Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Spinal Cord Injury
A study testing Proprioceptive stimulations in people with Spinal Cord Injuries, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
Trial summary
"Spinal cord injury (SCI) is a dramatic event resulting in a long-term handicap. Appropriate care from admission to the intensive care unit (ICU) is a key element not only for the survival of these patients but also to promote their recovery. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Spinal Cord Injuries
- What is being tested?
- Proprioceptive stimulations
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 40 participants
- Where
- 1 siteFrance
- Study dates
- 20 Oct 2021to 20 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- • Traumatic Spinal Cord Injury at or above level T6
- Age ≥ 18 years old
- No pregnancy
- Not being under guardianship
- Be affiliated to the French social security system
Who cannot join
- Orthopedic lesions or any medical condition that prevent the implementation of the protocol within ten days post-injury
- Severe brain injury
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
Bicêtre Hospital
Le Kremlin-Bicêtre, 94270
Bernard Vigué, MD PhD, 0033145216310, bernard.vigue@aphp.fr
Bernard Vigué, MD PhD
About this study
Official title: Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Spinal Cord Injury : a Randomized Controlled Trial
"Spinal cord injury (SCI) is a dramatic event resulting in a long-term handicap. Appropriate care from admission to the intensive care unit (ICU) is a key element not only for the survival of these patients but also to promote their recovery. Moreover, the studies on natural history of SCI have shown that most of the recovery occurs within the first 3 to 6 months post-injury. This period is therefore crucial for these patients. However, the environment of the ICU and the acute condition of the patients limit the rehabilitation possibilities. In such a context, functional proprioceptive stimulations (Vibramoov™ system, Techno Concept, France) could be a tool of interest.
By using tendon vibrations, the Vibramoov™ system allows to reproduce the proprioceptive signatures of cyclic movements such as walking. Some studies have already demonstrated the benefits of proprioceptive vibrations. However, so far, these benefits have only been studied at the chronic stage of neurological diseases.
Read more
The investigators hypothesized that early functional proprioceptive stimulations (FPS) may reduce spasticity and promote sensorimotor recovery in tetraplegic and high paraplegic patients.
To test their hypothesis, the investigators conduct a randomized controlled trial on 40 patients with traumatic SCI. These patients will be stratified into two groups according to the completeness of their lesion. Every patient will be included within ten days post-injury and receive either FPS, either sham stimulations to the joints of the lower limbs, 4 times a week during 8 weeks. the primary outcome measures will assess spasticity. the investigators also assess sensorimotor recovery, pain, muscle wasting, cognitive impairment and functional status. "
- Conditions
- Spinal Cord Injuries
- Being tested
- Proprioceptive stimulations, Sham stimulations
- Keywords
- spinal cord injuries, quadriplegia, proprioceptive stimulation, vibration, spasticity, intensive care units
- Medical subject headings
- Spinal Cord Injuries, Quadriplegia, Muscle Spasticity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Proprioceptive stimulationsDevice
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.
Sham stimulationsDevice
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement. Receives: Device: Proprioceptive stimulations |
| Control group | Sham comparator | Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations. Receives: Device: Sham stimulations |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in the modified Ashworth scale (MAS)
The MAS enables to assess spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)
Measured: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Changes in the angles of the muscle reaction in the modified Tardieu scale (MTS)
The MTS enables to assess the severity of spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (The outcome is reported in degree, from 0 to 180 degrees, higher values represent a higher dynamic component of spasticity)
Measured: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Changes in the quality of the muscle reaction in the modified Tardieu scale (MTS)
The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)
Measured: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Changes in the Spinal cord assessment tool for spastic reflexes (SCATS)
This score enables to asses global spasticity (Score range from 0 to 18, higher values represent a higher degree of spasticity)
Measured: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Secondary outcomes (12)
Changes in the visual analog scale for the auto-assessment of problematic spasticity
Score range from 0 to 100, higher values represent a higher degree of problematic spasticity.
Measured: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Changes in the visual analog scale for the auto-assessment of pain
Score range from 0 to 100, higher values represent a higher intensity of pain.
Measured: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury
Changes in the International standards for neurological classification of spinal cord injury (ISNCSCI) score
This score enables to assess sensorimotor recovery (Score range from 0 to 324, higher values represent a better outcome)
Measured: At inclusion, and at one week, one month, 2 months, 6 months and 1 year after the injury.
Changes in the quadriceps muscle thickness
"Measured with ultrasound, average of two measures (at the border between the lower third and upper two-thirds between the anterior superior iliac spine and the upper pole of the patella, and at the midpoint between the anterior superior iliac spine and the upper pole of the patella) (Measure in centimeters, higher values represent a better outcome)"
Measured: At inclusion, then twice a week during the first month, and at 2 months, 6 months and 1 year after the injury
Changes in the nitrogen balance,
Marker of protein losses (Measure in mmol/L, lower values represent a better outcome)
Measured: Every 48 hours during the first two weeks, and then once a week for six weeks
Number of days between the SCI and the verticalization at 45°
The attempt is successful if the position is maintained for 5 minutes without adverse effect. The verticalization protocol will remain the same as the one commonly used in the ICU. According to this protocol, verticalization will be progressive and mean blood pressure will be monitored continuously. The attempt is stopped if the patient feels unwell (signs of intolerance) or if the mean blood pressure drops by more than 20% (Measure in days, higher values represent a lower outcome)
Measured: Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
Number of days between the SCI and the verticalization at 70°
The attempt is successful if the position is maintained for 5 minutes without adverse effect. The verticalization protocol will remain the same as the one commonly used in the ICU. According to this protocol, verticalization will be progressive and mean blood pressure will be monitored continuously. The attempt is stopped if the patient feels unwell (signs of intolerance) or if the mean blood pressure drops by more than 20% (Measure in days, higher values represent a lower outcome)
Measured: Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
Changes in the Spinal cord independence measure (SCIM)
This measure enables to assess functional status (Score range from 0 to 100, higher values represent a better outcome)
Measured: At 2 months, 6 months and 1 year after the injury
Changes in the Montreal cognitive assessment (MoCA)
This measure enables to assess cognitive impairments (Score range from 0 to 30, higher values represent a better outcome)
Measured: Up to 1 month, then at 2 months and 1 year after the injury
Changes in the time to complete the bells cancellation test to assess cognitive impairments
This measure enables to assess cognitive impairments (Measure in minutes and seconds, lower values represent a better outcome)
Measured: Up to 1 month, then at 2 months and 1 year after the injury
Changes in the number of omissions in the bells cancellation test to assess cognitive impairments
This measure enables to assess cognitive impairments (Lower values represent a better outcome)
Measured: Up to 1 month, then at 2 months and 1 year after the injury
Changes in the digit span test to assess cognitive impairments
This measure enables to assess cognitive impairments (Higher values represent a better outcome)
Measured: Up to 1 month, then at 2 months and 1 year after the injury
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2021
- Study start20 Oct 2021 (estimated)
- Primary completion20 Sep 2024 (estimated)
- Study completion20 Sep 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Spinal Cord InjuriesStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Bernard VIGUE, Principal investigator, APHP
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05094752
- Sponsor's protocol ID
- 2020-A02015-34
- Acronym
- Tetra-Mouv
- Status last verified
- Sep 2021
- First submitted
- 22 Sep 2021
- Last updated
- 26 Oct 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Martinache F, de Crouy AC, Boutin A, Duranteau J, Vigue B. Early functional proprioceptive stimulation in high spinal cord injury: a pilot study. Front Rehabil Sci. 2025 Feb 26;6:1490904. doi: 10.3389/fresc.2025.1490904. eCollection 2025.
PubMed 40078600
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Spinal Cord Injury : a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT05094752
- Acronym / sponsor ID
- Tetra-Mouv / 2020-A02015-34
- Conditions
- Spinal Cord Injuries
- Keywords
- spinal cord injuries, quadriplegia, proprioceptive stimulation, vibration, spasticity, intensive care units
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Study start
- 20 Oct 2021 (estimated)
- Primary completion
- 20 Sep 2024 (estimated)
- Study completion
- 20 Sep 2024 (estimated)
- First posted
- 26 Oct 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
"Spinal cord injury (SCI) is a dramatic event resulting in a long-term handicap. Appropriate care from admission to the intensive care unit (ICU) is a key element not only for the survival of these patients but also to promote their recovery. Moreover, the studies on natural history of SCI have shown that most of the recovery occurs within the first 3 to 6 months post-injury. This period is therefore crucial for these patients. However, the environment of the ICU and the acute condition of the patients limit the rehabilitation possibilities. In such a context, functional proprioceptive stimulations (Vibramoov™ system, Techno Concept, France) could be a tool of interest.
By using tendon vibrations, the Vibramoov™ system allows to reproduce the proprioceptive signatures of cyclic movements such as walking. Some studies have already demonstrated the benefits of proprioceptive vibrations. However, so far, these benefits have only been studied at the chronic stage of neurological diseases.
The investigators hypothesized that early functional proprioceptive stimulations (FPS) may reduce spasticity and promote sensorimotor recovery in tetraplegic and high paraplegic patients.
To test their hypothesis, the investigators conduct a randomized controlled trial on 40 patients with traumatic SCI. These patients will be stratified into two groups according to the completeness of their lesion. Every patient will be included within ten days post-injury and receive either FPS, either sham stimulations to the joints of the lower limbs, 4 times a week during 8 weeks. the primary outcome measures will assess spasticity. the investigators also assess sensorimotor recovery, pain, muscle wasting, cognitive impairment and functional status. "
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Device: Proprioceptive stimulationsVibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement. |
| Control group | Sham comparator | Device: Sham stimulationsVibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- • Traumatic Spinal Cord Injury at or above level T6
Key exclusion criteria (2 listed)
- Orthopedic lesions or any medical condition that prevent the implementation of the protocol within ten days post-injury
- Severe brain injury
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Proprioceptive stimulationsVibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement. | Device | Intervention group |
| Sham stimulationsVibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations. | Device | Control group |
Primary outcome
Changes in the modified Ashworth scale (MAS)
Time frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
The MAS enables to assess spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)
Changes in the angles of the muscle reaction in the modified Tardieu scale (MTS)
Time frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
The MTS enables to assess the severity of spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (The outcome is reported in degree, from 0 to 180 degrees, higher values represent a higher dynamic component of spasticity)
Changes in the quality of the muscle reaction in the modified Tardieu scale (MTS)
Time frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)
Changes in the Spinal cord assessment tool for spastic reflexes (SCATS)
Time frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
This score enables to asses global spasticity (Score range from 0 to 18, higher values represent a higher degree of spasticity)
12 secondary outcomes
Changes in the visual analog scale for the auto-assessment of problematic spasticity
Time frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Changes in the visual analog scale for the auto-assessment of pain
Time frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury
Changes in the International standards for neurological classification of spinal cord injury (ISNCSCI) score
Time frame: At inclusion, and at one week, one month, 2 months, 6 months and 1 year after the injury.
Changes in the quadriceps muscle thickness
Time frame: At inclusion, then twice a week during the first month, and at 2 months, 6 months and 1 year after the injury
Changes in the nitrogen balance,
Time frame: Every 48 hours during the first two weeks, and then once a week for six weeks
Number of days between the SCI and the verticalization at 45°
Time frame: Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
Number of days between the SCI and the verticalization at 70°
Time frame: Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
Changes in the Spinal cord independence measure (SCIM)
Time frame: At 2 months, 6 months and 1 year after the injury
Changes in the Montreal cognitive assessment (MoCA)
Time frame: Up to 1 month, then at 2 months and 1 year after the injury
Changes in the time to complete the bells cancellation test to assess cognitive impairments
Time frame: Up to 1 month, then at 2 months and 1 year after the injury
Changes in the number of omissions in the bells cancellation test to assess cognitive impairments
Time frame: Up to 1 month, then at 2 months and 1 year after the injury
Changes in the digit span test to assess cognitive impairments
Time frame: Up to 1 month, then at 2 months and 1 year after the injury
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2021.
- Derived from this study: PubMed 40078600Martinache F, de Crouy AC, Boutin A, Duranteau J, Vigue B. Early functional proprioceptive stimulation in high spinal cord injury: a pilot study. Front Rehabil Sci. 2025 Feb 26;6:1490904. doi: 10.3389/fresc.2025.1490904. eCollection 2025.
- Individual participant dataSharing planned: No
Related trials for Spinal Cord Injuries
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Recruiting
Clinical Outcome Assessment for AT & BCI
Spinal Cord Injury, ALS (Amyotrophic Lateral Sclerosis)
Recruiting
Transcutaneous Spinal Cord Stimulation Combined With 4-Aminopyridine and Intensive Rehabilitation in SCI
Spinal Cord Injuries
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
RecruitingPhase 3
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury
Chronic Spinal Cord Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Bernard VIGUE principal investigator
APHP
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Proprioceptive stimulations in people with Spinal Cord Injuries, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 26 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in the modified Ashworth scale (MAS) (time frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05094752, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2021.